Publication: Distribution of exogenous metallothionein following intraperitoneal and intramuscular injection of metallothionein-deficient mice
| dc.contributor.author | Lewis, Katherine E. Lewis | |
| dc.contributor.author | Chung, Roger S. | |
| dc.contributor.author | West, Adrian K. | |
| dc.contributor.author | Chuah, Meng Inn | |
| dc.date.accessioned | 2017-11-08T16:31:56Z | |
| dc.date.available | 2017-11-08T16:31:56Z | |
| dc.date.issued | 2012 | |
| dc.description.abstract | Metallothionein-I/II (MT-I/II) is a small metal-binding protein with antioxidant and neuroprotective properties, which has been used experimentally as a neurotherapeutic agent in multiple conditions. Therefore it is important to determine whether exogenous MT-I/II is retained in specific organs or expelled from the body following intramuscular and intraperitoneal injection. The distribution of exogenous MT-IIA (the major human MT-I/II isoform) was examined in MT-I/II-deficient mice, by immunohistochemistry of tissue samples and western blotting of urine samples. MT-IIA was detected within epithelial cells of the kidney cortical and medullary tubules within 1 hour of either intramuscular or intraperitoneal injection. Additionally, MT-IIA was detected within the urine at 1 hour after injection, indicating rapid absorbance into the circulation and filtration through the kidney glomerulus. A portion of the intramuscularly-injected MT-IIA remained within the muscle for at least 24 hours after injection. No MT-IIA was observed within the liver or the brain after either a single injection or a series of MT-IIA injections. These results are consistent with earlier reports that exogenously administered MT-IIA does not cross the intact blood-brain barrier, although a receptor for MT-I/II (megalin) is present in the choroid plexus. We postulate that due to losses through the urine, circulating MT-IIA levels drop rapidly after injection and do not permit transport across the choroid plexus. Peptide analogues of MT-I/II with similar neuroactive properties (emtins) may be more suited for CNS delivery. | es |
| dc.format | application/pdf | es |
| dc.format.extent | 12 | es |
| dc.identifier.citation | Histology and histopathology, Vol. 27, n.º 11 (2012) | |
| dc.identifier.issn | 1699-5848 | |
| dc.identifier.issn | 0213-3911 | |
| dc.identifier.uri | http://hdl.handle.net/10201/54464 | |
| dc.language | eng | es |
| dc.publisher | F. Hernández y Juan F. Madrid. Universidad de Murcia. Departamento de Biología Celular e Histología | es |
| dc.rights | info:eu-repo/semantics/openAccess | es |
| dc.subject | MT-I/II-knockout mice | es |
| dc.subject | MT-IIA injection | es |
| dc.subject.other | CDU::5 - Ciencias puras y naturales::57 - Biología::577 - Bioquímica. Biología molecular. Biofísica | es |
| dc.title | Distribution of exogenous metallothionein following intraperitoneal and intramuscular injection of metallothionein-deficient mice | es |
| dc.type | info:eu-repo/semantics/article | es |
| dspace.entity.type | Publication | es |
Sin licencia Creative Commons.